Market Insights Unlocked: A Comprehensive Case Study on Market Assessment

Unveiling the Landscape: Market Assessment & Insights

In the rapidly evolving Asian pharmaceutical industry, understanding the competitive dynamics between branded and generic drugs has never been more critical. This case study explores how leading consulting firm DelveInsight helped a client navigate this complex terrain across Asian markets delivering actionable intelligence that translated into strategic advantage.

Purpose & Objective

The primary objective was to equip the client with a deep, data-driven understanding of the branded versus generic pharmaceuticals market in Asia. DelveInsight set out to identify unique value propositions and effective marketing approaches so the client could confidently differentiate their brand from generic alternatives. At the same time, the goal was to optimise resource allocation, focusing on high-potential market segments and launch strategies to maximise return on investment. 

Problem Statement: Addressing Emerging Challenges

The client faced specific challenges in the cardiovascular (CV) segment:

• They required an in-depth market assessment of brand versus generic pharmaceuticals in Asian markets following the patent-cliff phase.
• They needed to understand how generic competition would affect their branded products especially during the first two years after patent expiration.
• They also wanted a competitor analysis focusing on launch sequence and share distribution among generics to inform their strategic positioning.

Our Methodology: Structured, Insight-Driven

DelveInsight applied a comprehensive methodology built around three core pillars:

• Deep market analysis and forecasting: We developed a robust forecast model, enabling visibility into quarterly market-share dynamics for the two years post-patent expiry.
• Generic competition impact assessment: Strategies were crafted to mitigate sale erosion of branded pharmaceuticals in the face of generic entry anticipating and counteracting multiple competitors entering the space.
• Competitive intelligence & launch sequencing: By analysing rival generic launches and share distributions, we gave the client a clear view of the competitive landscape, enabling proactive strategy formulation.

Throughout this process, DelveInsight offered customised research solutions leveraging its healthcare-focused market intelligence team to deliver high-quality insights and real-time intelligence. 

Results: Turning Insight Into Impact

The outcome of this engagement empowered the client to act with foresight:

• They gained clarity on how generic competition penetrated the cardiovascular segment post patent-expiry, and how this impacted brand sales. 
• With the forecast model in hand, the client could anticipate shifts in market trends and competitor actions, enabling strategic adaptation early.
• The competitor analysis informed the client’s launch strategy optimal sequencing, resource allocation and share distribution awareness allowed for better positioning against generics.
• By aligning their brand strategy with the insights generated by DelveInsight, the client was able to maintain relevance and competitiveness even amid aggressive generic entries.

In summary, this case study highlights how targeted market assessment and actionable insights delivered by DelveInsight transformed uncertainty into strategic clarity. The client emerged better positioned to face generic incursions, optimise launches and maximise resource utilisation across the Asian pharma landscape.

Step into the future of pharma research with MarketAI - your all-in-one platform for uncovering market trends, benchmarking competitors, and identifying growth opportunities. Make informed decisions faster with AI-powered intelligence at your fingertips @ AI Powered Pharma Intelligence Platform